Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Clinical Trial

What's Up With The Jump In Viking Therapeutics Stock?

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments.

Benzinga

‘Next generation’ treatment to cure leukaemia given NHS approval

‘The biggest thing it offers is hope,’ says patient involved in clinical trial which cured cancer in significant portion of leukaemia sufferers

The Independent UK

Two UK clinical trials to assess impact of puberty blockers in young people

Multi-year studies announced after Cass review found ‘insufficient evidence’ about effects on children with gender dysphoria

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

NIH cuts impacted 74,000 clinical trial patients: study

The termination of federal research grants disrupted about 1 in 30 NIH-funded clinical trials.

Axios

Moderna Q3 2025 Earnings Call Transcript

Moderna, Inc (NASDAQ:MRNA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. MRNA is building positive momentum. Watch the momentum here This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visithttps://www.benzinga.com/apis/for a consultation. Operator…

Benzinga

First clinical trial testing pig kidney transplants in people launches in US

The small trial is the latest step in the quest for animal-to-human transplants.

Euronews

World’s first gene-edited pig kidney transplants begin in clinical trial

IN FULL

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Groundbreaking pig organ transplant trial gets underway

It’s the latest step in the quest for animal-to-human transplants

The Independent UK

In drug trials, lack of oversight of research ethics boards could put Canadian patients at risk

New drug approvals by Health Canada are based on the results of clinical trials. But before clinical trials can go ahead, they need to be approved by ethics committees known as Research Ethics Boards (REBs).

The Conversation

Teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS

Emily Henders received her CAR T last week at University College London Hospital (UCLH) as part of a global clinical trial

The Independent UK

Woman who lost vision can read again after ‘life-changing’ clinical trial

Sheila Irvine was one of 38 patients to be included in the world-first study

The Independent UK

‘Avid bookworm’ who lost vision ‘optimistic’ after implant helps her read again

Sheila Irvine, from Wiltshire, was one of the UK patients included in a groundbreaking clinical trial.

Evening Standard

Brain cancer patients left ‘devastated’ as new drug is rejected for NHS use

Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking

The Independent UK

Patients with brain cancer express disappointment after drug rejected for NHS

Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking.

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Pfizer Seeks Expanded Use Approval For Breast Cancer Drug

Pfizer Inc. (NYSE:PFE) on Tuesday announced the initial results from a clinical trial called HER2CLIMB-05.

The Independent UK

Company backed by Sam Altman gets FDA approval to trial ‘legal ecstasy’

Clinical trials of ‘safer MDMA’ could lead to new way of treating mental health problems, biotech firm says

Benzinga

EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial

Envoy Medical Inc. (NASDAQ:COCH) announced on Tuesday that it has received U.S. Food and Drug Administration (FDA) approval to expand its pivotal clinical trial for the fully implanted Acclaim cochlear implant to the final stage, based on promising three-month data from the first 10 patients.

Benzinga

Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) released topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ZYN002 in Fragile X syndrome (FXS).

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation

Pharmaceutical innovation saves lives. But not every “new” drug is truly new.

Benzinga

Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket

Shares of MBX Biosciences, Inc. (NASDAQ:MBX) rose sharply in pre-market trading after the company announced that it will provide topline results from its Phase 2 clinical trial of potential once-weekly canvuparatide for patients with chronic hypoparathyroidism on Sep. 22.

Benzinga

Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) on Wednesday released interim data from the Phase 2 pivotal portion of the PYNNACLE clinical trial evaluating rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation.

Benzinga

Eli Lilly's Jaypirca Surpasses Chemoimmunotherapy For Untreated Blood Cancer Patients

Eli Lilly and Co (NYSE:LLY) on Monday shared topline results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca (pirtobrutinib), a non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, versus chemoimmunotherapy (bendamustine plus rituximab), in treatment-naïve patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) without 17p deletions.

Benzinga

Jim Cramer Expects Palantir To Reach New All-Time High

Investor sentiment often swings with the ebb and flow of clinical trial results, technological advancements, and strategic corporate partnerships. In this volatile environment, market analysts and financial commentators provide crucial guidance to help navigate the complex landscape of investment opportunities.

LiveScience

Gum disease treatment slows the thickening of arteries, clinical trial shows

New trial results show that intense gum disease treatment reduces how much the carotid artery narrows in otherwise healthy individuals. This suggests oral health should be taken seriously as a contributing factor in cardiovascular disease.

Benzinga

BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know

BioXcel Therapeutics Inc. (NASDAQ:BTAI) experienced significant after-hours momentum, jumping 19.09% to $6.24 in the after-hours trading session on Tuesday, as investors got ready for the release of important clinical trial results.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.